The Vanguard Group just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though The Vanguard Group claims to own 11,198,268 shares. This represents 6.84% of PDL BioPharma.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever PDL BioPharma makes a similar move, sign up!
Other recent filings from the company include the following:
Current report, items 7.01 and 9.01
- Nov. 14, 2017
PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - Nov. 13, 2017
Notification of inability to timely file Form 10-Q or 10-QSB - Nov. 13, 2017
Pdl Biopharma’S Proposal To Acquire Neos Therapeutics Expires Today; - Nov. 8, 2017
PDL: Cook Williams Communications, Inc - Nov. 2, 2017